En savoir plus

Combining the medical, surgical, pharmacological and immunological expertise of the team and the resources of the FOCH hospital, we are studying the immune drivers of human respiratory diseases in various cohorts of patients with chronic inflammatory lung diseases, i) Lung allograft early and dysfunction, ii) GM-CSF signaling related conditions, iii) asthma and iv) pulmonary fibrosis.